ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA

This adverse event was reported 217 times

These drugs are most commonly taken by patients reporting ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA:

# Drug Count
0 METHOTREXATE SODIUM 57
1 METHOTREXATE 44
2 ROMIDEPSIN 39
3 PREDNISONE 28
4 CYCLOPHOSPHAMIDE 27
5 DOXORUBICIN 22
6 PREDNISOLONE 22
7 PREDNISOLONE ORAL 22
8 BRENTUXIMAB VEDOTIN 19
9 ETANERCEPT 18
See all common drugs associated with ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA

ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ROMIDEPSIN 39 0.0295
1 BRENTUXIMAB VEDOTIN 19 0.0031
2 SODIUM HYALURONATE 1 0.0020
3 PRALATREXATE 1 0.0019
4 GUSELKUMAB 10 0.0008
5 FLECAINIDE ACETATE 3 0.0008
6 FOSCARNET SODIUM 2 0.0007
7 ABACAVIR SULFATE AND LAMIVUDINE 2 0.0006
8 CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE 1 0.0005
9 AMPICILLIN SODIUM AND SULBACTAM SODIUM 1 0.0005
See all drugs enriched for association with ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA